Dermata Therapeutics Inc.
(DRMAW)
undefined
undefined%
At close: undefined
0.00
-100.00%
After-hours Dec 31, 1969, 07:00 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 |
Revenue | - | - | - | - | - |
Cost of Revenue | - | - | - | 322.00 | 1.35K |
Gross Profit | - | - | - | -322 | -1.35K |
Operating Income | -8.04M | -9.67M | -7.86M | -3.17M | -4.47M |
Interest Income | 247.22K | 63.57K | 45.61 | 197.27 | 250.75 |
Pretax Income | -7.79M | -9.61M | -7.90M | -3.24M | -4.72M |
Net Income | -7.79M | -9.61M | -7.95M | -3.43M | -4.97M |
Selling & General & Admin | 3.97M | 4.02M | 4.40M | 1.57M | 1.85M |
Research & Development | 4.07M | 5.65M | 3.46M | 1.61M | 2.62M |
Other Expenses | - | - | - | - | - |
Operating Expenses | 8.04M | 9.67M | 7.86M | 3.17M | 4.47M |
Interest Expense | - | - | 45.61K | 197.27K | 250.75K |
Selling & Marketing Expenses | - | - | - | - | - |
Cost & Expenses | 8.04M | 9.67M | 7.86M | 3.17M | 4.47M |
Income Tax | - | -9.67K | 45.61K | 197.27K | 250.75K |
Shares Outstanding (Basic) | 194.00K | 690.67K | 520.54K | 520.54K | 520.54K |
Shares Outstanding (Diluted) | 194.96K | 690.67K | 520.54K | 520.54K | 520.54K |
EPS (Basic) | -40.18 | -13.92 | -15.27 | -6.6 | -9.55 |
EPS (Diluted) | -39.98 | -13.92 | -15.27 | -6.6 | -9.55 |
EBITDA | 247.22K | - | -7.86M | -3.17M | -4.47M |
Depreciation & Amortization | 8.04M | 9.67M | 322.00 | 322.00 | 1.35K |